Bergen Brunswig board of directors elects new president and chief operating officer; expands board to thirteen.ORANGE, Calif.--(BUSINESS WIRE)--October 17, 1995--Bergen Brunswig Corporation (NYSE NYSE See: New York Stock Exchange :BBC BBC in full British Broadcasting Corp. Publicly financed broadcasting system in Britain. A private company at its founding in 1922, it was replaced by a public corporation under royal charter in 1927. ) today announced that its Board of Directors has elected Donald R. Roden, President, Chief Operating Officer Chief Operating Officer (COO) The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president. and a Director, increasing the Board membership to thirteen. Mr. Roden succeeds Dwight Steffensen, who announced his resignation as an officer last month to pursue other opportunities. A 25-year veteran of the healthcare industry, Mr. Roden draws upon his ability to understand the complex dynamics Complex dynamics the study of dynamical systems for which the phase space is a complex manifold. Complex analytic dynamics specifies more precisely that it is analytic functions whose dynamics it is to study. See also
Early in his career, Mr. Roden, as Group Vice President of Bergen's Health Applications Systems (HAS) division, helped to create the country's first major pharmaceutical benefits management (PBM PBM - play by mail. See play by electronic mail. ) company. Following his tenure with HAS, Mr. Roden directed his own consulting firm, Pracon Incorporated. By concentrating on the importance of pharmacoeconomics in disease management and results-oriented business applications important to managed care, the company grew to be the largest healthcare management and communications firm. Subsequent to the acquisition of his company by Reed Elsevier, Ltd., a major international publishing company, Mr. Roden served as Chief Executive of its medical business in North America. Commenting on the appointment, Robert E. Martini, Chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , said, "We're elated that Don will be leading the Bergen Brunswig team. Equally important to Mr. Roden's experience is his respected relationships with leaders of the manufacturing and professional communities, a strength that will be a catalyst to our future growth and expansion." Mr. Roden, 49, holds an M.B.A. in pharmaceutical marketing from Fairleigh Dickinson University Fairleigh Dickinson University, at Florham-Madison and Teaneck-Hackensack, N.J.; coeducational; incorporated and opened 1942 as a junior college, became a four-year college in 1948 and a university in 1956. in Rutherford, N.J. He is married and has two adult children. Bergen Brunswig Corporation, a Fortune 500 Company with annualized annualized Of or relating to a variable that has been mathematically converted to a yearly rate. Inflation and interest rates are generally annualized since it is on this basis that these two variables are ordinarily stated and compared. revenues in excess of $8.5 billion, is the nation's largest supplier of pharmaceuticals to the managed care market and the second largest wholesaler to the retail pharmacy market. Additionally, Bergen's new subsidiary, IntePlex(tm), focuses on the integration of Bergen's pharmaceutical, medical-surgical supply, and oncology divisions for one-stop-shop capabilities in the integrated healthcare marketplace. Bergen Brunswig is the only pharmaceutical distributor to provide both drugs and medical-surgical supplies on a national basis. Bergen Brunswig Corporation's operating entities include Bergen Brunswig Drug Company, Durr Medical, Alternate Site Distributors, and IntePlex. Note To Editors: Photo Available CONTACT: Bergen Brunswig Lisa Riordan, 800/840-5131 |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion